Significant Capital Investment in the Life Science Industry to Drive the European Pharmaceutical Excipient Market

The European pharmaceutical excipient market is estimated to grow at a CAGR of 5.3% during the forecast period. The increasing demand for pharmaceutical and biopharmaceutical drugs in the region significantly drives the growth of the market. Along with this, significant capital investment in the region is also expected to expand the market during the forecast period. 

Browse the full report description European Pharmaceutical Excipient Market Size, Share & Trends Analysis Report, By Product (Solubilizer & Surfactants/Emulsifiers, Polyols, Carbohydrates, and Specialty Excipients), By Formulation (Oral Formulation, Topical Formulations, Parenteral Formulations, and Other Formulations), and Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/european-pharmaceutical-excipient-market

Major economies contributing to the European pharmaceutical excipient industry include the UK, Germany, France, and Spain. Apart from these, some of the countries are also actively working in the biotech industry in the region which includes Sweden, Denmark, Belgium, Switzerland, and The Netherlands. Sweden is one of the major countries which received significant capital investment in the life science industry in the period of 2013-2017. As per MedCity, the country received a total investment of more than $5.0 billion during this period.  

The presence of global research institutes such as Karolinska Institute and Lund, Uppsala, and Göteborg Universities is attracting investment in the country. Such investment in the life science industry tends to drive the pharmaceutical industry of the region, which in turn, will drive the European pharmaceutical excipient during the forecast period.

Market Coverage

• Market number available for – 2018-2025
• Base year- 2018
• Forecast period- 2019-2025
• Segment Covered- By Product and By Formulation Type
• Regions Covered- Europe
• Competitive Landscape- Merck KGaA, DFE Pharma, BASF SE, Roquette Freres SA, and Lubrizol Corp. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

European Pharmaceutical Excipient Market- Segmentation

By Products

• Solubilizers & Surfactants/Emulsifiers
• Polyols
• Carbohydrates
• Specialty Excipients

By Formulations

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Formulations

European Pharmaceutical Excipient Market– Segment by Region 

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe